Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells. Michael S.

Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity. A study published in the open-access journal in PLOS Biology by Tianyu ...

Scientists have engineered a common probiotic bacterium to act like a microscopic drug factory that hunts down tumors and delivers cancer-killing compounds directly where they’re needed. Credit: ...

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden ...

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, largely due to metastasis and ...

Cooper Medical School of Rowan University (CMSRU) has launched the PhD in Cancer Cell Biology & Genomics (CCBG), a new doctoral program designed to train the next generation of cancer researchers and ...

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.

ADAM proteins, a family of a disintegrin and metalloproteinases, are pivotal regulators of cell signalling and adhesion, primarily through their ability to mediate ectodomain shedding. This process ...

A protein tied to ALS and dementia may have a much bigger role in disease than scientists realized. Researchers found that ...

The Undergraduate Cancer Biology Society (UCBS) was started in 2022 with inaugural President Sarah Elimam. Now our third year as a UAB Registered Student Organization, UCBS is excited to continue its ...